Lung Cancer Staging—A Clinical Practice Review

Lung cancer is the leading cause of cancer-associated death globally. Staging provides classification of the anatomic extent of cancer that is used consistently worldwide. Lung cancer staging is necessary for prognostication, to inform treatment options, and to allow accurate representation in clini...

Full description

Bibliographic Details
Main Authors: Ali B. Rueschhoff, Andrew W. Moore, Maykol R. Postigo Jasahui
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Respiration
Subjects:
Online Access:https://www.mdpi.com/2673-527X/4/1/5
_version_ 1797240395958059008
author Ali B. Rueschhoff
Andrew W. Moore
Maykol R. Postigo Jasahui
author_facet Ali B. Rueschhoff
Andrew W. Moore
Maykol R. Postigo Jasahui
author_sort Ali B. Rueschhoff
collection DOAJ
description Lung cancer is the leading cause of cancer-associated death globally. Staging provides classification of the anatomic extent of cancer that is used consistently worldwide. Lung cancer staging is necessary for prognostication, to inform treatment options, and to allow accurate representation in clinical trials. Staging also separates operable from inoperable disease. Since its introduction in the 1970s, the Tumor, Node and Metastasis (TNM) Staging System has undergone significant revisions, with the latest version, the eighth edition, being effective internationally since 2017. Advances in bronchoscopic and thoracoscopic technologies have expanded procedures to diagnose lung cancer and accurately define the anatomic stage. Understanding the advantages and disadvantages of available methods for staging lung cancer is critical to clinician decision making. In patients with lung cancer without distant metastases, the staging of mediastinal lymph nodes determines treatment options. To minimize the risk and cost, the most appropriate method of staging should identify the highest disease stage while carrying acceptable risk. Minimally invasive endoscopic needle techniques to stage the mediastinum are the first choice to assess for metastases in accessible lymph node stations. Surgical techniques are generally reserved for specific clinical situations, including following negative endoscopic needle techniques when suspicion for nodal involvement is high and to assess endoscopically inaccessible lymph nodes. This review provides a concise account of TNM staging of non-small cell lung cancer (NSCLC) and overview of procedures available for the staging of lung cancer.
first_indexed 2024-04-24T18:06:46Z
format Article
id doaj.art-318eacd491e7442c93b92a9a6a72c067
institution Directory Open Access Journal
issn 2673-527X
language English
last_indexed 2024-04-24T18:06:46Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Journal of Respiration
spelling doaj.art-318eacd491e7442c93b92a9a6a72c0672024-03-27T13:49:48ZengMDPI AGJournal of Respiration2673-527X2024-02-0141506110.3390/jor4010005Lung Cancer Staging—A Clinical Practice ReviewAli B. Rueschhoff0Andrew W. Moore1Maykol R. Postigo Jasahui2Division of Pulmonary Disease, Critical Care and Sleep Medicine, The University of Kansas School of Medicine, Kansas City, KS 66160, USADivision of Pulmonary Disease, Critical Care and Sleep Medicine, The University of Kansas School of Medicine, Kansas City, KS 66160, USADivision of Pulmonary Disease, Critical Care and Sleep Medicine, The University of Kansas School of Medicine, Kansas City, KS 66160, USALung cancer is the leading cause of cancer-associated death globally. Staging provides classification of the anatomic extent of cancer that is used consistently worldwide. Lung cancer staging is necessary for prognostication, to inform treatment options, and to allow accurate representation in clinical trials. Staging also separates operable from inoperable disease. Since its introduction in the 1970s, the Tumor, Node and Metastasis (TNM) Staging System has undergone significant revisions, with the latest version, the eighth edition, being effective internationally since 2017. Advances in bronchoscopic and thoracoscopic technologies have expanded procedures to diagnose lung cancer and accurately define the anatomic stage. Understanding the advantages and disadvantages of available methods for staging lung cancer is critical to clinician decision making. In patients with lung cancer without distant metastases, the staging of mediastinal lymph nodes determines treatment options. To minimize the risk and cost, the most appropriate method of staging should identify the highest disease stage while carrying acceptable risk. Minimally invasive endoscopic needle techniques to stage the mediastinum are the first choice to assess for metastases in accessible lymph node stations. Surgical techniques are generally reserved for specific clinical situations, including following negative endoscopic needle techniques when suspicion for nodal involvement is high and to assess endoscopically inaccessible lymph nodes. This review provides a concise account of TNM staging of non-small cell lung cancer (NSCLC) and overview of procedures available for the staging of lung cancer.https://www.mdpi.com/2673-527X/4/1/5non-small cell lung cancerendobronchial ultrasonographytransbronchial needle aspirationvideo-assisted thoracoscopic surgerypleuroscopy
spellingShingle Ali B. Rueschhoff
Andrew W. Moore
Maykol R. Postigo Jasahui
Lung Cancer Staging—A Clinical Practice Review
Journal of Respiration
non-small cell lung cancer
endobronchial ultrasonography
transbronchial needle aspiration
video-assisted thoracoscopic surgery
pleuroscopy
title Lung Cancer Staging—A Clinical Practice Review
title_full Lung Cancer Staging—A Clinical Practice Review
title_fullStr Lung Cancer Staging—A Clinical Practice Review
title_full_unstemmed Lung Cancer Staging—A Clinical Practice Review
title_short Lung Cancer Staging—A Clinical Practice Review
title_sort lung cancer staging a clinical practice review
topic non-small cell lung cancer
endobronchial ultrasonography
transbronchial needle aspiration
video-assisted thoracoscopic surgery
pleuroscopy
url https://www.mdpi.com/2673-527X/4/1/5
work_keys_str_mv AT alibrueschhoff lungcancerstagingaclinicalpracticereview
AT andrewwmoore lungcancerstagingaclinicalpracticereview
AT maykolrpostigojasahui lungcancerstagingaclinicalpracticereview